PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
about
Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapies.Renal cell carcinoma: the search for a reliable biomarker.Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging.Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.
P2860
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
@en
PET/CT imaging of renal cell carcinoma with
@nl
type
label
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
@en
PET/CT imaging of renal cell carcinoma with
@nl
prefLabel
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
@en
PET/CT imaging of renal cell carcinoma with
@nl
P2093
P2860
P1476
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
@en
P2093
Adam R Metwalli
Baris Turkbey
Cathy D Vocke
Frank I Lin
Gennady Bratslavsky
Gideon Kwarteng
Juanita Weaver
Maria J Merino
Maria L Lindenberg
Miriam Anver
P2860
P2888
P304
P356
10.1007/S00261-015-0599-1
P577
2016-01-01T00:00:00Z